Regulation of the SHP-2 tyrosine phosphatase by a novel cholesterol- and cell confluence-dependent mechanism
Document Type
Journal ArticlePublication Date
2003-03-04Keywords
Animals; Annexin A2; Aorta; Cattle; Cell Adhesion; Cell Division; Cell Line; Cell Membrane; Cells, Cultured; Cholesterol; Cyclodextrins; Digitonin; Endothelium, Vascular; *Gene Expression Regulation, Enzymologic; Indicators and Reagents; Intracellular Signaling Peptides and Proteins; Microscopy, Fluorescence; Phosphorylation; Precipitin Tests; Protein Binding; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; SH2 Domain-Containing Protein Tyrosine Phosphatases; Signal Transduction; Subcellular Fractions; Tyrosine; src Homology DomainsLife Sciences
Medicine and Health Sciences
Metadata
Show full item recordAbstract
Endothelial cells approaching confluence exhibit marked decreases in tyrosine phosphorylation of receptor tyrosine kinases and adherens junctions proteins, required for cell cycle arrest and adherens junctions stability. Recently, we demonstrated a close correlation in endothelial cells between membrane cholesterol and tyrosine phosphorylation of adherens junctions proteins. Here, we probe the mechanistic basis for this correlation. We find that as endothelial cells reach confluence, the tyrosine phosphatase SHP-2 is recruited to a low-density membrane fraction in a cholesterol-dependent manner. Binding of SHP-2 to this fraction was not abolished by phenyl phosphate, strongly suggesting that this binding was mediated by other regions of SHP-2 beside its SH2 domains. Annexin II, previously implicated in cholesterol trafficking, was associated in a complex with SHP-2, and both proteins localized to adhesion bands in confluent endothelial monolayers. These studies reveal a novel, cholesterol-dependent mechanism for the recruitment of signaling proteins to specific plasma membrane domains via their interactions with annexin II.Source
J Biol Chem. 2003 May 16;278(20):18360-7. Epub 2003 Feb 27. Link to article on publisher's siteDOI
10.1074/jbc.M210701200Permanent Link to this Item
http://hdl.handle.net/20.500.14038/32990PubMed ID
12611902Related Resources
Link to article in PubMedae974a485f413a2113503eed53cd6c53
10.1074/jbc.M210701200
Scopus Count
Collections
Related items
Showing items related by title, author, creator and subject.
-
Crystal structure of the catalytic domain of protein-tyrosine phosphatase SHP-1Yang, Jian; Liang, Xiaoshan; Niu, Tian-Qi; Meng, Wuyi; Zhao, Zhizhuang Joe; Zhou, G. Wayne (1998-10-17)The crystal structures of the protein-tyrosine phosphatase SHP-1 catalytic domain and the complex it forms with the substrate analogue tungstate have been determined and refined to crystallographic R values of 0.209 at 2.5 A resolution and 0.207 at 2.8 A resolution, respectively. Despite low sequence similarity, the catalytic domain of SHP-1 shows high similarity in secondary and tertiary structures with other protein-tyrosine phosphatases (PTPs). In contrast to the conformational changes observed in the crystal structures of PTP1B and Yersinia PTP, the WPD loop (Trp419-Pro428) in the catalytic domain of SHP-1 moves away from the substrate binding pocket after binding the tungstate ion. Sequence alignment and structural analysis suggest that the residues in the WPD loop, especially the amino acid following Asp421, are critical for the movement of WPD loop on binding substrates and the specific activity of protein-tyrosine phosphatases. Our mutagenesis and kinetic measurements have supported this hypothesis.
-
Abnormal T cell receptor signal transduction of CD4 Th cells in X-linked lymphoproliferative syndromeNakamura, Hiroyuki; Zarycki, Jodi; Sullivan, John L.; Jung, Jae U. (2001-09-01)The molecular basis of X-linked lymphoproliferative (XLP) disease has been attributed to mutations in the signaling lymphocytic activation molecule-associated protein (SAP), an src homology 2 domain-containing intracellular signaling molecule known to interact with the lymphocyte-activating surface receptors signaling lymphocytic activation molecule and 2B4. To investigate the effect of SAP defects on TCR signal transduction, herpesvirus saimiri-immortalized CD4 Th cells from XLP patients and normal healthy individuals were examined for their response to TCR stimulation. CD4 T cells of XLP patients displayed elevated levels of tyrosine phosphorylation compared with CD4 T cells from healthy individuals. In addition, downstream serine/threonine kinases are constitutively active in CD4 T cells of XLP patients. In contrast, TCR-mediated activation of Akt, c-Jun-NH(2)-terminal kinases, and extracellular signal-regulated kinases in XLP CD4 T cells was transient and rapidly diminished when compared with that in control CD4 T cells. Consequently, XLP CD4 T cells exhibited severe defects in up-regulation of IL-2 and IFN-gamma cytokine production upon TCR stimulation and in MLRs. Finally, SAP specifically interacted with a 75-kDa tyrosine-phosphorylated protein upon TCR stimulation. These results demonstrate that CD4 T cells from XLP patients exhibit aberrant TCR signal transduction and that the defect in SAP function is likely responsible for this phenotype.
-
Structural basis for substrate specificity of protein-tyrosine phosphatase SHP-1Yang, Jian; Cheng, Zhiliang; Niu, Tian-Qi; Liang, Xiaoshan; Zhao, Zhizhuang Joe; Zhou, G. Wayne (2000-02-08)The substrate specificity of the catalytic domain of SHP-1, an important regulator in the proliferation and development of hematopoietic cells, is critical for understanding the physiological functions of SHP-1. Here we report the crystal structures of the catalytic domain of SHP-1 complexed with two peptide substrates derived from SIRPalpha, a member of the signal-regulatory proteins. We show that the variable beta5-loop-beta6 motif confers SHP-1 substrate specificity at the P-4 and further N-terminal subpockets. We also observe a novel residue shift at P-2, the highly conserved subpocket in protein- tyrosine phosphatases. Our observations provide new insight into the substrate specificity of SHP-1.